CARA Overview
Upcoming Projects (CARA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CARA)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (CARA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CARA)
-
FDA rejects Acacia Pharma's amisulpride for postoperative nausea and vomiting
Tickers: ACPH.BR, CARA
Occurred on: Oct 08, 2018 -
Cara Therapeutics (CARA) Expects Top-Line Data From Phase 2b Study of Oral CR845 in Chronic Pain Patients in First Half of 2017
Ticker: CARA
Occurred on: Jun 29, 2017 -
Cara Therapeutics (CARA) Announces Data From Quantitative Phase 1 Trial Measuring Respiratory Safety of I.V. CR845
Ticker: CARA
Occurred on: Apr 24, 2017 -
Top-line data of Part A Phase 2/3 IV CR845 in treating Uremic pruritus due 1Q 2017
Ticker: CARA
Occurred on: Mar 28, 2017 -
Cara Therapeutics (CARA) Initiates Enrollment of Phase 2b Trial Evaluating Oral CR845 in Chronic Pain Patients
Ticker: CARA
Occurred on: Sep 15, 2016 -
Initiation of Phase 2b Trial of Oral CR845 in Chronic Pain set for Second Half of 2016
Ticker: CARA
Occurred on: Sep 15, 2016 -
Phase 2/3 Registration Program of CR845 for Dialysis Patients suffering from Uremic Pruritus Set to Initiate H1 of 2016
Ticker: CARA
Occurred on: Jun 29, 2016 -
Cara Therapeutics Initiates Adaptive Phase 2/3 Trial of I.V. CR845 for Treatment of Chronic Kidney Disease-Associated Pruritus
Ticker: CARA
Occurred on: Jun 29, 2016 -
Cara Therapeutics Announces Removal of FDA Clinical Hold on CLIN3001 Postoperative Pain Trial for I.V. CR845
Ticker: CARA
Occurred on: Apr 20, 2016 -
Cara to meet with FDA to discuss CLIN3001 trial in postoperative pain in Q2 of 2016
Ticker: CARA
Occurred on: Apr 20, 2016 -
Cara Therapeutics (CARA) to Sponsor Symposium and Present Poster on CR845 at ANESTHESIOLOGY 2015 Annual Meeting
Ticker: CARA
Occurred on: Oct 26, 2015
Strategic Initiatives (CARA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!